Line Selection Guide: How MJ150-L and MJ150 Work Together from Pilot to Commercial ОРД Production

Introduction

In planning ОРД and растворитель-based трансдермальный пластырь production lines, teams usually face three core questions: Which оборудование should we start with? When should we move to a commercial line? and How do we keep process continuity during scale-up? A smart line selection strategy not only saves time and cost, but also reduces process shifts and validation risk when moving from development to commercial production.

Common Decision Pitfalls

• Using capacity as the only decision factor: Focusing only on output while ignoring the need for validation documents and traceable records during development and registration.
• Disconnected logic between pilot and commercial lines: Formulation parameters and покрытие/drying windows are not fully defined on the pilot line, leading to rework once the commercial line is installed.
• Equating “can produce” with “can be registered”: Overlooking the need to align batch records, audit trails, and operator training between development and commercial оборудование.

Switching Timing and Inheritance Path

• Use the process window and validation readiness as the switching signal: Scale-up should be triggered by a stable process window and complete validation elements, not just by a sudden increase in orders.
• Build a unified method card and batch record framework: Define common templates covering formulation viscosity ranges, target покрытие thickness windows, drying logic, and how intermediate storage and packaging are linked.
• Keep people and SOPs aligned: Once SOPs are established on the MJ150-L, moving to the MJ150 mainly becomes a matter of adjusting line speed, web width, and module configuration while keeping the same industrial logic.

HUANGHAI Line Selection Recommendations

• Development and pilot phase: Use the MJ150-L to establish formulation windows and finalize SOPs. Ensure that the record system and соответствие pathway are clearly defined at this stage.
• Commercial scale-up: Switch to the MJ150 to increase capacity while preserving the same process logic and validation approach. Focus on line speed, web width, and module combinations for throughput and flexibility.
• End-to-end line planning: Plan the покрытие line together with downstream slitting and packaging so that the transition from “плёнка formation” to “individual sachets” is smooth and time-efficient.

*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.

*Designed to meet Class I Div 1 / ATEX explosion-proof стандарты for safe transdermal растворитель handling.

Conclusion

Starting with the MJ150-L to stabilize methods and validation, then moving to the MJ150 for capacity scale-up, is a more controlled and compliant path. When process, documentation, and people are treated as one integrated system, scale-up can maintain consistency instead of introducing new variability.

Related Products

• MJ150-L ОРД плёнка покрытие машина
• MJ150 ОРД & растворитель-Based трансдермальный пластырь плёнка Making машина
• фармацевтический плёнка производство Solutions

\n

---

Frequently Asked Questions

Q: What is the difference between an ОРД плёнка and a трансдермальный пластырь?

A: Oral Dissolving Films (ОРД) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar растворитель-cast плёнка покрытие processes. Huanghai's MJ150 ОРД машина supports both applications on a single platform with approximately 2 working days of changeover time.

Q: What production output can I expect from a Huanghai ОРД машина?

A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either машина with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.

Q: What drying technology does Huanghai use for ОРД production?

A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform плёнка thickness, reduced edge curl, and better АФИ distribution across the плёнка web. An optional far-infrared heating module adds 20–30% drying efficiency for растворитель-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ОРД оборудование supplier to Sinopharm, Shanghai фарма, and Fosun фарма.

Q: What are the GMP требования for ОРД production оборудование?

A: ОРД производство оборудование must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent стандарты (EU GMP Annex 1, ChGMP) for other markets. Key требования: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; данные integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ОРД машины meet these стандарты—all product contact surfaces use фармацевтический-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP соответствие documentation.

Q: Can Huanghai машины produce stripe-coated or multi-formula ОРД films?

A: Yes. Huanghai holds a patent for multi-formula stripe покрытие (Patent CN117323228A), enabling two different АФИ formulations to be applied side-by-side in a single покрытие pass. This eliminates the need for multiple покрытие/drying cycles when producing combination-drug ОРД products. Competitors require manual multi-layer покрытие with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-АФИ ODFs for cardiovascular or CNS indications) where покрытие efficiency directly impacts production economics.